![]() |
| Source: Dentium Q1-Q3 Financial Revision Report |
DentalGoodNews|On September 30, 2026, Dentium released revised financial reports for the first quarter, half-year, and first three quarters of 2025. The reports show that, due to corrections to the revenue recognition timing of its Vietnamese subsidiary BMS VINA (Dentium Vietnam) and adjustments to the provision for expected credit losses on Accounts Receivable, the company restated core financial data for multiple reporting periods in 2025. Among them, the Net Profit Attributable to Shareholders of the Parent Company for the first three quarters of 2025 was revised down from the previously disclosed KRW 13.695 billion (approximately RMB 68.475 million) to KRW 10.537 billion (approximately RMB 52.685 million), a decrease of 23.05%.
In the revision for the first quarter of 2025 (26th period), Dentium's single-quarter revenue remained unchanged at KRW 64.998 billion (approximately RMB 325 million), but Net Profit Attributable to Shareholders of the Parent Company was slightly raised from KRW 13.260 billion (approximately RMB 66.300 million) to KRW 13.333 billion (approximately RMB 66.665 million). This change mainly stemmed from minor adjustments to selling expenses and administrative expenses. Operating Profit rose from KRW 10.113 billion (approximately RMB 50.565 million) to KRW 10.208 billion (approximately RMB 51.040 million), an increase of about 0.94%; Q1 Basic Earnings Per Share (BEPS) increased from KRW 1,538 to KRW 1,546.
![]() |
| Source: Dentium 2025 Q1 Financial Revision Report |
Entering the first half of 2025, revised revenue remained at KRW 123.532 billion (approximately RMB 618 million), but Net Profit Attributable to Shareholders of the Parent Company was revised down from KRW 8.143 billion (approximately RMB 40.715 million) to KRW 8.014 billion (approximately RMB 40.070 million), a decrease of approximately KRW 128 million (approximately RMB 640,000). In the revision notes, the company stated that this restatement reflected adjustments to the revenue recognition logic for sales by subsidiary BMS VINA, as well as the latest assessment results based on the expected credit loss (ECL) model.
![]() |
| Source: Dentium 2025 H1 Financial Revision Report |
A larger adjustment appeared in the first three quarters of 2025. After revision, cumulative revenue for the first three quarters decreased from KRW 184.018 billion (approximately RMB 920 million) to KRW 179.697 billion (approximately RMB 898 million), a decrease of approximately KRW 4.320 billion (approximately RMB 21.600 million), or 2.35%; during the same period, Net Profit Attributable to Shareholders of the Parent Company shrank from KRW 13.695 billion (approximately RMB 68.475 million) to KRW 10.537 billion (approximately RMB 52.685 million), with a profit gap of KRW 3.158 billion (approximately RMB 15.790 million), and Basic Earnings Per Share decreased from KRW 1,588 to KRW 1,222.
![]() |
| Source: Dentium Q1-Q3 Financial Revision Report |
In terms of R&D investment, total R&D expenditure for the first three quarters of 2025 was KRW 6.547 billion (approximately RMB 32.735 million), of which labor costs accounted for 85%, or KRW 5.587 billion (approximately RMB 27.935 million); the ratio of R&D expenses to operating revenue was raised from the previously disclosed 3.6% to 3.7%.
In terms of asset structure, as of the end of September 2025, Dentium's total assets were revised to KRW 753.909 billion (approximately RMB 3.770 billion), down approximately KRW 365 million (approximately RMB 1.825 million) from before the revision; Current Assets were adjusted to KRW 324.152 billion (approximately RMB 1.621 billion), with the increase in Accounts Receivable provisions being the main reason for the asset reduction; total liabilities remained at KRW 329.350 billion (approximately RMB 1.647 billion).
In terms of dividend policy, the company did not pay cash dividends on common shares in any quarter of 2025, prioritizing surplus for expanding production and technological R&D; by comparison, the company's total dividends for fiscal year 2024 were KRW 5.174 billion (approximately RMB 25.870 million).
![]() |
| Source: Dentium 2026 Semi-Annual Report |
According to previous reports by DGN, Dentium's consolidated operating revenue for the first half of 2026 (January-June) was KRW 160.729 billion (approximately RMB 771 million), a year-on-year increase of 1.03%; Net Profit Attributable to Shareholders of the Parent Company was KRW 31.109 billion (approximately RMB 149 million), a year-on-year increase of 78.84%; consolidated Operating Profit was KRW 30.539 billion (approximately RMB 147 million), a year-on-year increase of 21.55%; Operating Profit from the main dental business in the first half was KRW 16.043 billion (approximately RMB 77.006 million), down 38.22% from the same period last year.
| About DGN:DentalGoodNews (DGN) is a trusted professional media platform dedicated to the global dental industry. We deliver in-depth coverage of corporate news, policy & regulation, investment & funding, and clinical frontiers — serving dental institutions, device manufacturers, investors, and industry researchers worldwide. Contact us: haodeya@dongxizixun.com |